Updated:
Talis Biomedical Corp
Talis Biomedical Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001584751, and its reported industry...
Overview
Talis Biomedical Corp is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001584751, and its reported industry is Laboratory Analytical Instruments. In 10-K filed on 2024-03-28, it reported annual revenue of USD 2,134,000; net income of USD -62,007,000; total assets of USD 94,674,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Talis Biomedical Corp
- Former names in filing history
- SlipChip Corp (2013-08-20 to 2017-10-17)
- Classification
- Company
- Industry (SIC)
- 3826 — Laboratory Analytical Instruments
- Headquarters
- Chicago, IL, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001584751
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | $2.1M | -$62.0M | $94.7M | $76.7M | -$53.2M | |
| FY2022USD | $4.8M | -$113.0M | $169.3M | $130.2M | -$100.1M | |
| FY2021USD | — | -$192.0M | $265.8M | $232.5M | -$171.4M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Talis Biomedical Corp in Altss
Track this company’s investors, transactions and relationships in Altss.